The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Phase 3 study (TRIUMPH-Outcomes), condition: Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD). The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/m\^2 or higher and Atherosclerotic Cardiovascular Disease and/or chronic kidney disease. The study will last for about 5 years. Participants will have up to 27 clinic visits with the study doctor. Enrolment: 10000 participants. Status: active, not recruiting. No topline or peer-reviewed results are verified for publication on this Record for this study — registry facts only.